VPS33A

VPS33A is a Sec1/Munc18 (SM)-family protein that functions as a core subunit of the HOPS and CORVET tethering complexes to regulate SNARE-mediated membrane fusion at late endosomes, multivesicular bodies, autophagosomes, and lysosomes. VPS33A is recruited to HOPS through a direct interaction with VPS16 (residues 642–736), and structure-guided mutations at this interface abolish both complex assembly and lysosome fusion in cells (PMID:23901104, PMID:25783203). It engages cognate syntaxin SNAREs—STX17 for autophagosome–lysosome fusion and STX11/dSyntaxin16 for lysosomal fusion—with its domain 3a critical for SNARE complex assembly, and a phosphoserine switch in the STX17 N-peptide regulates fusion competency (PMID:19158398, PMID:30655294, PMID:40855995, PMID:38585203). Loss-of-function mutations cause defective biogenesis of lysosome-related organelles including melanosomes, platelet dense granules, and renin granules in the buff mouse, and the homozygous R498W missense mutation causes MPS-plus syndrome in humans, characterized by heparan sulphate accumulation and lysosomal over-acidification (PMID:12538872, PMID:28013294, PMID:31070736).

1. 2003 High

   Positional cloning of the buff mouse established VPS33A as the first mammalian component of the class C VPS/tethering complex and demonstrated that its loss causes defective biogenesis of lysosomes, melanosomes, and storage granules, linking SM-protein function to lysosome-related organelle pathways in mammals.

   Evidence Positional cloning and phenotypic analysis of the buff mouse

   PMID:12538872

   Open questions at the time

   • No structural information on VPS33A or its complex interfaces
   • Mechanism by which the D251E mutation impairs organelle biogenesis was unknown
   • Whether VPS33A and the paralog VPS33B have overlapping or distinct functions was unresolved
2. 2009 High

   Genetic and biochemical studies in Drosophila and mouse distinguished VPS33A as specifically required for late endosome–lysosome and autophagosome–lysosome fusion, showing it binds lysosomal syntaxins (dSyntaxin16) while VPS33B preferentially binds early endosomal SNAREs, and confirmed its necessity for MVB–lysosome fusion in mammalian urothelial cells.

   Evidence Drosophila null alleles with in vitro SNARE binding assays; buff mouse EM and lysosomal enzyme assays in urothelial cells

   PMID:19158398 PMID:19566896

   Open questions at the time

   • Structural basis of VPS33A–VPS16 and VPS33A–SNARE interactions unknown
   • Whether VPS33A roles in autophagy are separable from endosomal fusion roles was unclear
3. 2013 High

   The crystal structure of human VPS33A confirmed its SM-family fold and defined the VPS16 binding interface, establishing that VPS16 residues 642–736 are necessary and sufficient for HOPS recruitment and enabling structure-guided dissection of complex assembly.

   Evidence X-ray crystallography, mutagenesis, in vitro binding assays, and cell-based rescue

   PMID:23901104

   Open questions at the time

   • SNARE-binding surfaces on VPS33A not yet mapped structurally
   • How other HOPS subunits depend on VPS33A–VPS16 assembly was untested
4. 2015 High

   Structure-guided mutagenesis demonstrated that disruption of the VPS33A–VPS16 interface blocks both endosome–lysosome and autophagosome–lysosome fusion, and that the buff D251E mutation selectively impairs autophagosome–lysosome fusion while paradoxically enhancing association with the autophagic SNARE complex (STX17–VAMP8–SNAP29), revealing that binding affinity and productive SNARE engagement are distinct.

   Evidence Co-immunoprecipitation, siRNA depletion, fluorescent dextran delivery, autophagy flux assays in cells and buff mice

   PMID:25783203 PMID:26259518

   Open questions at the time

   • How enhanced SNARE binding leads to fusion failure was mechanistically unexplained
   • Whether D251E affects SNARE complex disassembly or proofreading was not tested
5. 2017 Medium

   Analysis of patient-derived fibroblasts carrying the VPS33A R498W mutation revealed that VPS33A regulates lysosomal pH homeostasis, with the mutation causing lysosomal over-acidification and heparan sulphate accumulation characteristic of MPS-plus disease, a function partially separable from canonical endocytic/autophagic fusion.

   Evidence Patient fibroblast analysis, lysosomal pH measurement, GAG quantification, siRNA knockdown in HeLa cells

   PMID:28013294

   Open questions at the time

   • Mechanism linking VPS33A to pH regulation is unknown—whether direct or via impaired ion channel trafficking
   • Whether this phenotype is specific to R498W or general to VPS33A loss was not distinguished
6. 2018 Medium

   BioID proximity labeling showed that VPS33A resides with CORVET, HOPS, and class III PI3K complex components in a compartment distinct from VPS33B, establishing non-overlapping interactomes for the two SM-protein paralogs at a proteome-wide scale.

   Evidence BioID proximity biotinylation and mass spectrometry

   PMID:29778605

   Open questions at the time

   • Proximity does not prove direct binding for PI3K complex components
   • Functional significance of VPS33A–PI3K proximity was not tested
7. 2019 Medium

   Biochemical and structural analyses showed that VPS33A R498W destabilizes protein folding, leading to proteasomal degradation of VPS33A and associated HOPS/CORVET subunits, and that proteasome inhibitor treatment rescues protein levels, explaining the molecular basis of MPS-plus pathogenesis; concurrently, FLIM-FRET revealed that VPS33A engages the STX17 N-peptide to control autophagosomal SNARE trimerization, with a phosphoserine acting as a fusion-competency switch.

   Evidence Crystal structure analysis with immunoblotting and proteasome inhibitor rescue in patient fibroblasts; FLIM-FRET in HeLa cells with mutagenesis

   PMID:30655294 PMID:31070736

   Open questions at the time

   • In vitro reconstitution of VPS33A-catalyzed SNARE assembly has not been achieved
   • Kinase responsible for STX17 N-peptide phosphorylation unidentified
   • Whether bortezomib rescue restores function in vivo remains untested
8. 2024 Low

   A suppressor screen in C. elegans identified a gain-of-function mutation in domain 3a of VPS33A that compensates for loss of the SM protein VPS45, implicating domain 3a specifically in SNARE complex assembly during endosomal trafficking.

   Evidence Genetic suppressor screen in C. elegans with site-specific mutation analysis

   PMID:38585203

   Open questions at the time

   • No biochemical validation that domain 3a directly contacts SNAREs
   • Cross-species relevance to mammalian VPS33A not confirmed
   • Single suppressor allele—specificity of the domain 3a requirement is tentative
9. 2025 Medium

   VPS33A was shown to regulate renin granule biogenesis in juxtaglomerular cells via the SNAP23–STX11–VAMP8 SNARE complex, extending its organelle-specific functions to secretory granules of the renin–angiotensin system.

   Evidence Buff mouse analysis, siRNA knockdown, Co-IP, and electron microscopy in As4.1 cells

   PMID:40855995

   Open questions at the time

   • Whether VPS33A directly catalyzes SNAP23–STX11–VAMP8 complex assembly or acts indirectly through HOPS tethering is unresolved
   • Physiological impact on blood pressure regulation in buff mice not characterized

• Key unresolved questions include: the structural basis of VPS33A engagement with SNARE bundles, whether its pH-regulatory role is mechanistically distinct from tethering/fusion, and how domain 3a catalyzes SNARE complex assembly at the molecular level.
• No high-resolution structure of VPS33A bound to a SNARE complex
• In vitro reconstitution of VPS33A-catalyzed SNARE assembly is lacking
• Mechanism of lysosomal pH regulation by VPS33A is unknown